| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.071 | 0.2 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.075 | 0.2 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |